Literature DB >> 8634551

The legacy of Edward Jenner.

M M Levine.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8634551      PMCID： PMC2350929          DOI： 10.1136/bmj.312.7040.1177

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Assessing vaccine efficacy in the field. Further observations.

Authors:  W A Orenstein; R H Bernier; A R Hinman
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

2.  Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.

Authors:  M M Levine; C Ferreccio; R E Black; R Germanier
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

3.  A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

Authors:  K L Kotloff; J P Nataro; G A Losonsky; S S Wasserman; T L Hale; D N Taylor; J C Sadoff; M M Levine
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

4.  Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.

Authors:  C H Simanjuntak; P O'Hanley; N H Punjabi; F Noriega; G Pazzaglia; P Dykstra; B Kay; A Budiarso; A R Rifai
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

5.  Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.

Authors:  M B Rennels; R I Glass; P H Dennehy; D I Bernstein; M E Pichichero; E T Zito; M E Mack; B L Davidson; A Z Kapikian
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

6.  Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.

Authors:  J D Clemens; C Ferreccio; M M Levine; I Horwitz; M R Rao; K M Edwards; B Fritzell
Journal:  JAMA       Date:  1992-02-05       Impact factor: 56.272

7.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

Authors:  L Gustafsson; H O Hallander; P Olin; E Reizenstein; J Storsaeter
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

8.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Authors:  D A Herrington; D F Clyde; G Losonsky; M Cortesia; J R Murphy; J Davis; S Baqar; A M Felix; E P Heimer; D Gillessen
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962
  8 in total
  2 in total

1.  Vaccines, malaria, and a host of resistance.

Authors:  M Dobson
Journal:  BMJ       Date:  1996-07-13

Review 2.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.